Recent congressional testimony and internal shifts have brought NIH reforms and leadership changes into the national spotlight . National Institutes of Health Director Jayanta Bhattacharya recently shared his vision with the U.S. Senate Committee on Health, Education, Labor, and Pensions . He emphasized transparency and new biomedical research priorities . However, his testimony happened during intense scrutiny over a shrinking workforce, canceled clinical trials, and an increasing number of political appointees at the agency .
As the Trump administration works to reshape the country’s top biomedical research agency, these NIH reforms and leadership changes are fundamentally altering how the organization operates . Supporters argue that greater political oversight makes the agency more accountable to voters . On the other hand, critics warn that abandoning traditional hiring practices could harm the stability of long-term scientific research .
Navigating Grant Disruptions and Clinical Trials
During his Senate testimony, Dr. Bhattacharya highlighted several new programs designed to build public trust . These include creating an office to handle the replication crisis, combining peer review processes, and modernizing data systems to use real-world information . He also stressed the importance of women’s health research and vaccine policy .
However, lawmakers aggressively questioned the director about recent grant cancellations and how they affect patients . Senator Bernie Sanders stated that the agency defunded over 300 clinical trials, and Senator Maggie Hassan pointed to 118 canceled cancer trials . Senator Patty Murray added that one in 30 trials faced disruptions, which affected more than 74,000 participants . In response, Bhattacharya estimated that the agency permanently terminated only about a dozen trials . He explained that the agency reinstated many trials after court cases or after renegotiating them to remove specific political components . He also mentioned that despite a partial government shutdown in October 2025, the agency successfully spent its entire budget for the fiscal year .
Workforce Cuts and Growing Vacancies
The agency is also dealing with a significantly smaller staff . Senator Tim Kaine noted that the organization’s workforce dropped from 21,000 employees down to 17,300, though federal records from late 2025 placed the number around 17,500 . Kaine added that the agency lost roughly 1,100 doctoral scientists during this period . Senator Susan Collins warned that these job cuts severely hurt early-career researchers . She pointed out that competing nations are actively stepping in to recruit American scientific talent . Grantees have also reported frustrating communication problems and funding delays .
Leadership vacancies represent another major challenge . Currently, 15 of the 27 institutes and centers that make up the agency have open leadership posts, with many operating under temporary directors . Senator Murray pointed out that advisory council seats also remain empty . Bhattacharya acknowledged these staffing shortages and recognized the urgent need to fill both leadership roles and vacant council positions .
The Shift Toward Political Appointees
Historically, the agency operated with very few political appointees, which allowed career scientists and outside experts to guide major decisions . However, following the 2024 election, the current administration began placing more political appointees in powerful roles . By late June 2025, the number of political appointees grew to nine, up from four the previous year .
These new appointments include Seana Cranston, a former Republican congressional staffer . She replaced a 40-year career civil servant as the NIH Director’s chief of staff . Another appointee, Michael Allen, became the chief operating officer for the National Institute of Allergy and Infectious Diseases . Several senior career officials were either placed on administrative leave or departed early in the year . This included Lawrence Tabak, who previously served as the agency’s interim leader . According to Mike Lauer, a former grants chief for the agency, a conservative roadmap known as Project 2025 argued that unaccountable insiders should not control research funding for decades .
Changing the Hiring Process
The administration has also changed how it selects the directors for its 27 institutes and centers . In the spring of 2025, officials fired or placed five directors on leave . Later, the search committee for the National Institute of Mental Health was abruptly disbanded before being quickly reconvened . By October, a personal friend of Vice President JD Vance filled the directorship for the National Institute of Environmental Health Sciences without any apparent search process . Furthermore, late in the year, Bhattacharya announced the departure of the neuroscience institute’s leader . He noted that the Department of Health and Human Services chose to pursue the transition despite the director’s exceptional performance .
Moving away from the traditional use of external search committees, a press team recently stated that an internal leadership team will now review applicants and make hiring decisions . Mark Histed, an agency scientist, argued that external committees are essential for preventing politicization and ensuring scientific success . In response to these sweeping changes, Representative Diana DeGette sponsored a bill in late January 2026 to cap the number of political appointees at the agency . As Lauer observed, while increased political control can align an agency more closely with voters, it also brings the risk of unstable budgets and a potential loss of crucial scientific expertise .
